RapidAI

RapidAI

Website:

RapidAI

Sector:

Healthcare

Founded:

2011

About RapidAI

RapidAI is a diagnostic technology company specializing in neuroimaging analysis to support accurate diagnostic decisions for aneurysm and stroke patients. Focused on advancing medical technology, RapidAI offers clinical trial solutions with the mission of redefining traditional neurological care. Their software also provides analytic insights aimed at enhancing operational efficiency in healthcare. Founded in 2011 by Gregory Albers and Karim Karti, RapidAI is headquartered in San Francisco, CA.

RapidAI Industries Press Mentions

Stay in the know about the latest news on RapidAI Industries

Investors in RapidAI Industries

Discover investors in RapidAI Industries stock and explore their portfolio companies

RapidAI Industries Management

Leadership team at RapidAI Industries

Management Team

Gregory Albers MD

Co-Founder & Scientific Lead

Amit Phadnis

Chief Innovation and Technology Officer

Roland Bammer Ph.D

Karim Karti

Chief Executive Officer

Board Members

Erol Dervis

Lennertz & Co.
GIF Example

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for RapidAI, register or login.

  • RapidAI's current valuation
  • RapidAI's stock price
  • Explore available deals for RapidAI and other companies
  • Access deal offering documents
  • Pre-Ipomarket's exclusive data and insights, including:
    • Cap tables showing funding history by Share Class and Liquidity Preferences
    • Key Company Highlights
    • Detailed Business Model
    • Identified Risk Factors

Interested in RapidAI?

Buy

By registering, you agree to StockMe's Terms of Use. Already registered? Log in

Frequently Asked Questions

How to invest in RapidAI shares?

Accredited investors can purchase pre-IPO stock in companies like RapidAI through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.

How to sell RapidAI shares?

Shareholders have the option to sell their RapidAI stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.

Why choose Pre-Ipomarket?

pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."